# Combination Study With MVA BN and Dryvax

> **NCT00082446** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 91 (actual)

## Conditions studied

- Smallpox

## Interventions

- **BIOLOGICAL:** Live vaccinia virus vaccine
- **BIOLOGICAL:** MVA Smallpox Vaccine
- **BIOLOGICAL:** MVA Smallpox Vaccine
- **OTHER:** Placebo
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00082446
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082446, "Combination Study With MVA BN and Dryvax". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00082446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*